DOCSLIB.ORG

Internet Bookmarks for Aids

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Internet Bookmarks for Aids New Mexico AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 999 INTERNET BOOKMARKS FOR AIDS NOTES: · Addresses for Internet web pages (URLs, or Uniform Resource Locators) must be entered exactly. · Some web sites require that you register before you can obtain information, especially news services and on-line journals. · There can be several reasons for getting a “File Not Found” error message. Verify the address, and try again later. The problem might be with the web server (computer) where the web pages are stored. · To find a web site if you don’t have the address, use a search engine to look for the organization or web page name. · Consider the source when you get information off the Internet. Just because it’s on a web page doesn’t mean it’s accurate! · These links are available on the Internet at http://www.aidsinfonet.org/999-bookmarks.html · A few web sites that are particularly useful are indicated by an asterisk and Bold Type. Revised December 1, 2000 I. ADVOCACY ACT UP-New York Canadian HIV/AIDS Legal Network http://www.actupny.org/ http://www.aidslaw.ca ACT UP/Golden Gate Correctional HIV Consortium http://www.actupgg.org/ http://www.silcom.com/~chc/ ACT UP Philadelphia Mothers’ Voices http://www.critpath.org/actup/ http://www.mvoices.org/ African American AIDS Policy and Training Institute National Association of People With AIDS http://www.BlackAIDS.org http://www.napwa.org/ AIDS Action Council National Association on HIV Over Fifty http://www.aidsaction.org/ http://www.hivoverfifty.org AIDS Drug Assistance Program (ADAP) Working Group Nat’l Ass’n for Victims of Transfusion-Acquired AIDS http://www.aidsinfonyc.org/awg/index.html http://www.navta.org/ AIDS Empowerment and Treatment International National Minority AIDS Council http://www.aidseti.org/ http://www.nmac.org AIDS/HIV Law and Policy Resource National Native American AIDS Prevention Center http://www.critpath.org/aidslaw/index.html#resource http://www.nnaapc.org/ AIDS in Prison Project New York HIV/AIDS SNP Site (Re: Managed Care) http://www.aidsinfonyc.org/aip/index.html http://www.generes.net/Projects.htm AIDS Treatment Access – Cuba http://www.cubasida.net/ II. ALTERNATIVE THERAPIES Alternative Medicine Homepage http://www.pitt.edu/~cbw/altm.html Being Alive Website http://www.mbay.net/~bngalive/index.html Alternative Medicine Review http://www.thorne.com/altmedrev/index.html Boston Buyers Club http://www.vitatime.com/ Armenicum AIDS Drug Information Page http://www-personal.umich.edu/~kpearce/armenicum.htm *Direct AIDS Alternative Information Resources (DAAIR) Treatment Information Sheets Bastyr University http://www.aids.org/daair/TIPINFO.NSF/ http://www.bastyr.edu/ 29fb3e9f39d028d0852563f80083b471?OpenView A Project of the New Mexico AIDS Education and Training Center. Partially funded by the National Library of Medicine and the New Mexico Department of Health Fact Sheets can be downloaded from the Internet at http://www.aidsinfonet.org INTERNET BOOKMARKS FOR AIDS Page 2 II. ALTERNATIVE THERAPIES (Continued) DHEA (dehydroepiandrosterone) Home Page Keep Hope Alive Home Page http://gator.naples.net/~nfn03605/ http://www.execpc.com/~keephope/keephope.html Doc Misha’s HIV Wellness Center Marijuana as a Medicine http://www.docmisha.com/hiv/index.html http://www.calyx.com/~olsen/MEDICAL/medical.html HIVnALIVE Nutritional Project http://www.hivnalive.org/nutrproj/index.htm Medibolics http://www.medibolics.com/ Houston Buyers Club http://www.houstonbuyersclub.com/ MotherNature’s Health Library http://www.mothernature.com/ency/concern/hiv_support.asp Institute for Traditional Medicine http://www.itmonline.org/disorder.htm National Institutes of Health, National Center for Complementary and Alternative Therapies International Bibliographic Information on Dietary http://nccam.nih.gov Supplements Database http://www.nal.usda.gov/fnic/IBIDS/ Oxytherapy.com - Oxygen & Ozone Therapies http://www.oxytherapy.co Jon D. Kaiser, MD, Wellness Center http://www.jonkaiser.com/ Sensible Guide to Using Complementary Therapies for HIV www3.sympatico.ca/devan.nambiar III. BASIC SCIENCE AIDS Pathology *Merck Manual Home Edition http://www-medlib.med.utah.edu/WebPath http://www.merck.com /pubs/mmanual_home/ /TUTORIAL/AIDS/AIDS.html#10 NOVA Online – Surviving AIDS Glossary of HIV/AIDS Related Terms http://www.pbs.org/wgbh/nova/aids/ http://www.sfaf.org/treatmnt/glossary/webglos.html Ohio State Microbiology 521 Harvard AIDS Institute Basic Science links http://www.biosci.ohio-state.edu/~mgonzalez/Micro521.html http://www.hsph.harvard.edu/hai/resources/basic/index.html Stanford HIV RT and Protease Gene Database HIV Resistance.com http://hivdb.stanford.edu/hiv/ http://www.hivresistance.com/ Understanding the Immune System HIV Sequence Database WWW Home Page http://rex.nci.nih.gov/PATIENTS/INFO_TEACHER/ http://hiv-web.lanl.gov/ bookshelf/NIH_immune/index.html HIV-1 Structures Viral Resistance Web Site http://louis.bidmc.harvard.edu/structure.pages http://www.viral-resistance.com/ /structure.Links.html Washington State Univ. Microbiology course - Immunity *Immunology bookcase http://www.wsu.edu:8080/~hurlbert/pages/Chap15.html http://www.medicine.dal.ca/pim/home.htm WWW Virtual Library Microbiology & Virology http://microbiol.org/vl_micro/index.htm A Project of the New Mexico AIDS Education and Training Center. Partially funded by the National Library of Medicine and the New Mexico Department of Health Fact Sheets can be downloaded from the Internet at http://www.aidsinfonet.org INTERNET BOOKMARKS FOR AIDS Page 3 IV. CHILDREN, YOUTH & AIDS Action for Orphans National Pediatric and Family HIV Resource Center http://orphans.fxb.org/ http://www.pedhivaids.org/ Camp Heartland Pediatric HIV/AIDS Links http://www.digital.com/info/camp/ http://mail.med.upenn.edu/~jstoller/pedaids.html Children With AIDS Project of America Positively Kids http://www.aidskids.org/ http://www.aidsinfonyc.org/posikids/index.html Clinical Management: Pediatrics TeenAIDS.org http://www.iapac.org/pediatricsidx.html http://www.teenaids.org/index.shtml Elizabeth Glaser Pediatric AIDS Foundation Teens Teach Kids about HIV! http://www.pedaids.org/ http://www.caps.ucsf.edu/hotindex.html HIV Positive Youth *Women & Children with HIV Menu http://members.aol.com/marinersc/connect/pozyouth/ http://www.hivpositive.com/f-Women /WoChildMenu.html Justin’s HIV and AIDS Info Page http://members.tripod.com/~Justin2001/ Young People and AIDS from The Body http://www.thebody.com/whatis/children.html Medscape Clinical Mgmnt v.12 – Pediatric HIV Infection http://hiv.medscape.com/medscape/hiv/ YouthHIV.org clinicalmgmt/cm.v12/public/index-cm.v12.html http://www.youthhiv.org/ National Pediatric AIDS Network http://www.npan.org/ V. CLINICAL TRIALS Adult AIDS Clinical Trials Group (AACTG) Community Research Initiative on AIDS http://aactg.s-3.com/ http://www.aidsinfonyc.org/cria/index.html ÆGIS Clinical Trials Knowledgebase Division of Acquired Immunodeficiency Syndrome http://www.aegis.org/pubs/trials/index.html (DAIDS), Nat’l Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH) AIDS Clinical Trial Results Database http://www.niaid.nih.gov/research/Daids.htm http://www.actis.org/actis.asp?URL=resultdb&VIEW=general Forum for Collaborative HIV Research *AIDS Clinical Trials Information Service http://www.gwumc.edu/chpr/hivforum.htm http://www.actis.org/ Health Prevention Trials Network American Foundation for AIDS Research (AmFAR) http://www.hptn.org http://www.amfar.org/ Office of AIDS Research Australian National Centre in HIV Virology Research http://www.nih.gov/od/oar/ http://www.hiv.edu.au/ Pediatric AIDS Clinical Trials Group Canadian HIV Trials Network http://pactg.s-3.com/ http://www.hivnet.ubc.ca/ctn.html Trials Database at UC San Francisco ClinicalTrials.gov http://never.ucsf.edu:8000/tsearch http://www.clinicaltrials.gov/ Women’s Interagency HIV Study Community Programs For Clinical Research on AIDS http://www.statepi.jhsph.edu/wihs/index.html http://www.cpcra.org/ A Project of the New Mexico AIDS Education and Training Center. Partially funded by the National Library of Medicine and the New Mexico Department of Health Fact Sheets can be downloaded from the Internet at http://www.aidsinfonet.org INTERNET BOOKMARKS FOR AIDS Page 4 VI. CONFERENCE SITES & CONFERENCE REPORTS 12th National HIV/AIDS Update Conference NATAP conference reports http://www.nauc.org/ http://www.natap.org AIDS 2000: XIII International AIDS Conference site National Conference on Women and HIV, May 1997 http://www.aids2000.com/ http://www.ama-assn.org/special/hiv/newsline /conferen/women/womeet.htm AIDS Impact http://www.aidsimpact.com Retrovirus & Opportunistic Infections Conferences http://www.retroconference.org/ Conferences – HIV/AIDS http://www.pslgroup.com/dg/hivaids.htm Salvage Therapy Workshop http://www.intmedpress.com/salvagetherapy/ International Association of Physicians in AIDS Care HIV AIDS Conferences Seventh European Conference On Clinical Aspects and http://www.iapac.org/confidx.html Treatment of HIV Infection http://www.euro-aids99.com/hiv99_09.htm International Conference on Drug Therapy in HIV Infection http://www.hiv2000.com/ Women at Durban http://caho.aegis.com/womenatdurban/index.html *Medscape http://hiv.medscape.com/Home/Topics/AIDS/directories/dir- XIII Int’l AIDS Conference – AIDS Webcast 2000 AIDS.ConfSummaries.html http://www.webcast.aids2000.com/ XIV International Conference on AIDS http://www.aids2002.com VII. DISSIDENTS (AIDS Doesn’t Exist or HIV Isn’t the Cause) The AIDS Heresies
Load more

Recommended publications
  • Adverse Reactions to HIV Vaccines: Medical, Ethical, and Legal Issues
    Adverse Reactions to HIV Vaccines: Medical, Ethical, and Legal Issues September 1995 OTA-BP-H-163 GPO stock #052-003-01429-7 Recommended Citation: U.S. Congress, Office of Technology Assessment, Adverse Reactions to HIV Vaccines: Medical, Ethical, and Legal Issues, OTA-BP-H-163 (Washington, DC: U.S. Government Printing Office, September 1995). oreword IDS researchers are investigating new vaccines that would prevent infection with HIV and reduce the spread of AIDS. Some have argued that product liabil- ity concerns have discouraged investment in HIV vaccine research and devel- opment. The purpose of this OTA background paper is to describe the current state of development of HIV vaccines, and to discuss what is known about adverse reac- tions that may occur. The background paper provides an overview of ethical issues that arise in the conduct of HIV vaccine trials. The report also discusses alternatives to the current product liability system to encourage the development of HIV vaccines and to fairly compensate those who are harmed as a result of adverse reactions to the vaccine. This background paper was prepared in response to a request from the Subcommittee on Health of the House Ways and Means Committee. It is eleventh in OTA’s series of studies on HIV-related issues. The preceding papers in this series were: Do Insects Transmit AIDS? (9/87), AIDS and Health Insurance: An OTA Survey (2/88), How Effective is AIDS Education? (6/88), The Impact of AIDS on the Kaiser Permanente Medical Care Program (Northern California Region) (7/88), How Has Federal Research on AIDS/HIV Disease Contributed to Other Fields? (4/90), The Effectiveness of Drug Abuse Treatment: Implications for Controlling AIDS/HIV Infection (9/90), HIV in the Health Care Workplace (11/91), The CDC’s Case Definition of AIDS: Implications of the Proposed Revisions (8/92), Difficult-to-reuse Needles for the Prevention of HIV Infection Among Injecting Drug Abusers (10/92), and External Review of the Federal Centers for Disease Control and Prevention’s HIV Prevention Programs (9/94).
    [Show full text]
  • International Guidelines on HIV/AIDS and Human Rights 2006 Consolidated Version
    International Guidelines on HIV/AIDS and Human Rights 2006 Consolidated Version Second International Consultation on HIV/AIDS and Human Rights Geneva, 23-25 September 1996 Third International Consultation on HIV/AIDS and Human Rights Geneva, 25-26 July 2002 Organized jointly by the Office of the United Nations High Commissioner for Human Rights and the Joint United Nations Programme on HIV/AIDS OFFICE OF THE UNITED NATIONS HIGH COMMISSIONER FOR HUMAN RIGHTS Material contained in this publication may be freely quoted or reprinted, provided credit is given and a copy containing the reprinted material is sent to the Office of the United Nations High Commissioner for Human Rights, CH-1211 Geneva 10, and to UNAIDS, CH-1211 Geneva 27, Switzerland. The designations employed and the presentation of the material in this publication do not imply expression of any opinion whatsoever on the part of the Secretariat of the United Nations or UNAIDS concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Published jointly by the Office of the United Nations High Commissioner for Human Rights and the Joint United Nations Programme on HIV/AIDS. HR/PUB/06/9 UN PUBLICATION Sales No. E.06.XIV.4 ISBN 92-1-154168-9 © Joint United Nations Programme on HIV/AIDS (UNAIDS) 2006. All rights reserved. Publications produced by UNAIDS can be obtained from the UNAIDS Information Centre. Requests for permission to translate UNAIDS publications—whether for sale or for noncommercial distribution—should also be addressed to the Information Centre at the address below, or by fax, at +41 22 791 4187, or e-mail: [email protected].
    [Show full text]
  • HIV Infection, AIDS, and Cancer
    cancer.org | 1.800.227.2345 HIV Infection, AIDS, and Cancer People with HIV infection or AIDS are at higher risk for some types of cancer than people who are not infected. Here we will discuss the risks of certain cancers in people with HIV infection or AIDS, what tests these people might need to look for cancers early, and how these cancers are generally treated. ● What Are HIV and AIDS? ● How Are HIV and AIDS Related to Cancer? ● What Can People with HIV or AIDS Do to Try to Lower Their Risk of Cancer or Find It Early? ● How Is Cancer Treated in People with HIV or AIDS? What Are HIV and AIDS? Acquired immune deficiency syndrome, better known as AIDS, is caused by infection with the human immunodeficiency virus (HIV). AIDS is the most advanced stage of HIV infection. Over time, the virus attacks and destroys the body’s immune system (the system that protects the body from disease). Without a fully working immune system, a person is at risk for getting other infections that usually don’t affect healthy people. These are called opportunistic infections. People with HIV also have a greater risk of getting certain types of cancer, such as Kaposi sarcoma1, lymphoma2, and cervical cancer3, as well as other health problems. Many of these problems can threaten life. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 More than 1 million people in the United States are now living with HIV infection, and nearly 500,000 are living with AIDS. Women account for about 1 out of 4 people infected with HIV in this country.
    [Show full text]
  • Hiv/Aids and Its Impact Hiv/Aids
    Section 1 HIV/AIDS and its impact Section 2 Legal and policy HIV/AIDS AND ITS IMPACT framework Section 3 Employers need a clear understanding of HIV/AIDS and the impact of the epidemic in order to plan a workplace programme. Developing workplace policies This Section helps you fi nd basic information about inf HIV and inf AIDS, and their implications for society as a whole as well as for Section 4 the world of work. Implementing workplace programmes To view the contents, click on the headings on the left or scroll through the pages. Section 5 Good practice and lessons learnt HIV/AIDS - the facts The Human Immunodefi ciency Virus (HIV) is a virus that weakens the body’s immune system, ultimately causing AIDS. The Acquired Immune Defi ciency Syndrome (AIDS) is a cluster of medical conditions linke to HIV infection. These conditions include diseases known as inf 2 opportunistic infections, as well as certain cancers. To date there is no cure, but the onset of AIDS can be slowed and symptoms relieved with the appropriate use of antiretroviral drugs (ARVs). A person with HIV is not necessarily sick, and can go on working for a number of years after infection. ARVs make it possible for people to continue living full and productive lives. You are in Section 1 The ILO Code of Practice on HIV/AIDS and the world of work (Appendix I) and the accompanying HIV/AIDS and its impact Education and Training Manual contain basic facts about the epidemic and its implications, conditions that contribute to inf HIV and AIDS – the facts vulnerability, and the gender dimension.
    [Show full text]
  • Coversheet for Thesis in Sussex Research Online
    A University of Sussex DPhil thesis Available online via Sussex Research Online: http://eprints.sussex.ac.uk/ This thesis is protected by copyright which belongs to the author. This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the Author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the Author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Please visit Sussex Research Online for more information and further details Knowledge Accumulation and Vaccine Innovation: Lessons from Polio and HIV/AIDS Ohid Yaqub Doctor of Philosophy University of Sussex Submitted in September 2008 ii I hereby declare that this thesis has not been submitted, either in the same or different form, to this or any other university for a degree. Ohid Yaqub iii To my parents and Corinne, Two worlds that should not be separate. iv ACKNOWLEDGEMENTS This thesis was funded by the Economic and Social Research Council and supervised by Paul Nightingale. Paul is a supervisor who is extremely generous with his time, ideas and encouragement; and who manages to make academia look extremely fun. His energy and enthusiasm were most important to me when I really thought the ship was sinking. I cannot thank him enough and feel privileged to have worked with him. My first opportunity to pursue some of the ideas in this thesis was under the supervision of Ed Steinmueller and Aldo Geuna.
    [Show full text]
  • Republic of ARMENIA Country Profile
    Anush PERIKHANYAN MPH Yerevan State Medical University Department of Public Health Republic of ARMENIA Country profile http://www.who.int/countries/arm/en/ 1 Armenia - a lower-middle income country 3-5% (officially)prevalence of HCV among the general population (2013). HCV in 3rd highest rate in CIS countries (Georgia 6.7% Armenia/CIS and Uzbekistan 6.5%) Hepatitis C in Armenia- 44% have HCV genotype 1 37% have genotype 3 19% have genotype 2 Maistat L., Golovin S., Deineka O. and T, Khan. Hepatitis C in Eastern Europe and Central Asiа: Civil Society Respone to the Epidemics; 2015. http://www.aidsalliance.org.ua/ru/news/pdf/28.10.2015/EECA%20HCV%20EN.pdf. Accessed November 9, 2015 injecting drug users imprisoned persons patients getting hemodialysis commercial sex workers patients with tuberculosis healthcare workers oncological patients healthy population 70% HCV among 60% different groups is: people who inject drugs; 50% people who use intranasal drugs; recipients of infected blood products or 40% invasive procedures in health-care facilities with inadequate infection control practices ; children born to mothers infected with HCV ; 30% people with sexual partners who are HCV- infected; 20% people with HIV infection; prisoners or previously incarcerated persons; 10% people who have had tattoos or piercings 0% 1 2 In 2015 effective N3691 order-A “Methodological guideline for epidemiological management of viral Management hepatitis B, C”. of Hepatitis C The epidemiological control of viral hepatitis C is done by the National Center for Disease Control of the in Armenia Republic of Armenia (NCDC), which provides methodological management of prevention and regular control activities of HCV.
    [Show full text]
  • Qualitative Study to Explore the Knowledge and Attitude of Pregnant Women Regarding HIV/AIDS Testing in Kotayk Region and in Yerevan, Armenia
    Qualitative study to explore the knowledge and attitude of pregnant women regarding HIV/AIDS testing in Kotayk region and in Yerevan, Armenia Utilizing Professional Publication Framework Henrik Khachatryan, MD, MPH candidate, American University of Armenia Primary Adviser: M. Thompson, MS, DrPH Secondary Adviser: K. White, RN, PhD, CNAA October 2005 Table of Contents INTRODUCTION ...........................................................................................................................................................1 Background Information and Literature review....................................................................................................1 Rationale for the Research and Research Questions.............................................................................................4 METHODS AND MATERIALS........................................................................................................................................5 Study design...........................................................................................................................................................5 Study population ....................................................................................................................................................5 Sampling and Study Setting...................................................................................................................................6 Data collection Instrument.....................................................................................................................................6
    [Show full text]
  • CURRICULUM VITAE Updated on Jan 24, 2020
    T. Davtyan, Armenia CURRICULUM VITAE Updated on Jan 24, 2020 Surname Davtyan First name(s) Tigran Affiliation and official address Rhea Pharmaceutical Armenia LLC Armenia, 0084, Yerevan Gusan Sherami St., 2 Building (Malatia-Sebastia adm. district) Republic of Armenia Tel.: (+374-) 91 400994, 98-55-96-29 E-mail: [email protected] [email protected] Present Positions: Professor, Chief Scientist Rhea Pharmaceutical Armenia LLC Home address: Michurin str. 5, 23, 375041, Yerevan, Republic of Armenia. Tel: +374 10 55-96-29 Date and Place of birth: 1 December, 1966, Yerevan, Armenia Nationality: Armenian Citizenship: Republic of Armenia Passport ARM, AH0248176, 24 OCT 2006, 009 ID № 1112660259 Marital status: Married, has 2 children, 3 grandchild Education (degrees, dates, universities) 2016 Professor. Field: Biology 2003 Doctor of Biological Sciences (ScD). Field: Molecular Biology 1993 Candidate of Biological Sciences (Ph.D); Field :Genetics and Immunology 1989-1992 Ph.D. student, Laboratory of Genetic Mechanisms of Cell Malignization And Differentiation, Institute of Cytology, St. Petersburg, Russia. 1983-1988 Yerevan State Medical University, Faculty of Pharmacy Specialization (specify) Drug Design and quality control, HIV/AIDS and clinical immunology; Viral infections; immunity and stress resistance; Molecular mechanisms and Genetic regulation of innate immune response; Autoinflammation; 1 T. Davtyan, Armenia Career/Employment (employers, positions and dates) 2011- 2019 Director of Analytical Laboratory of Scientific Centre of Drug and Medical Thechnology Experttise JSC 1999 - 2011 Head of HIV-Clinical Trail Laboratory of the ARMENICUM Research Center, Yerevan, Rep. of Armenia. 1998 - 2006 Consultant on Science, Laboratory of Immunology, The Second Clinical Hospital of the Yerevan State Medical University, Rep.
    [Show full text]
  • Individual Responsibility Concerning HIV
    SIT Graduate Institute/SIT Study Abroad SIT Digital Collections Independent Study Project (ISP) Collection SIT Study Abroad Fall 2006 Individual Responsibility Concerning HIV Transmission Among MSM: A Comparative Study of the Effectiveness of NGO Intervention Policies and Their rP actical Applications Within the United Kingdom, Australia, and the Netherlands Martha Kienbaum SIT Study Abroad Follow this and additional works at: https://digitalcollections.sit.edu/isp_collection Part of the Mass Communication Commons, and the Public Health Education and Promotion Commons Recommended Citation Kienbaum, Martha, "Individual Responsibility Concerning HIV Transmission Among MSM: A Comparative Study of the Effectiveness of NGO Intervention Policies and Their rP actical Applications Within the United Kingdom, Australia, and the Netherlands" (2006). Independent Study Project (ISP) Collection. 290. https://digitalcollections.sit.edu/isp_collection/290 This Unpublished Paper is brought to you for free and open access by the SIT Study Abroad at SIT Digital Collections. It has been accepted for inclusion in Independent Study Project (ISP) Collection by an authorized administrator of SIT Digital Collections. For more information, please contact [email protected]. Individual Responsibility Concerning HIV Transmission Among MSM: A comparative study of the effectiveness of NGO intervention policies and their practical applications within the United Kingdom, Australia, and the Netherlands “We need to break the silence, banish the stigma and discrimination and ensure total inclusiveness within the struggle against AIDS.” Nelson Mandela Martha Kienbaum Fall 2006 School for International Training Amsterdam Project Advisor: Tobias Dörfler Academic Advisor: Ginni Fleck 1 Abstract This study investigates the complexities involved in utilizing the terms of individual responsibility for the construction of HIV prevention campaigns that target men who have sex with men.
    [Show full text]
  • Demetre C Daskalakis MD
    Demetre C Daskalakis MD MPH New York City Department of Health and Mental Hygiene 42-09 28th Street, Long Island City, NY 11101 Cell: 347-989-5513 Office: 347-396-7728 [email protected] EDUCATION Degree Programs: 2012 Harvard School of Public Health Boston, MA Masters of Public Health 1999 NYU School of Medicine New York, NY Medical Doctor 1995 Columbia University New York, NY Bachelor of Arts Post-Graduate Medical Training: 1999-2002 Harvard- Beth Israel Deaconess Boston, MA Residency (Medicine) 2002-2003 Harvard- Beth Israel Deaconess Boston, MA Chief Residency 2003-2005 Harvard-Partners Healthcare Boston, MA Fellowship (Infectious Dis) PROFESSIONAL EXPERIENCE 2017-Current New York City Department of Health and Mental Hygiene Deputy Commissioner- Division of Disease Control Oversee all infectious disease related public health programming at the NYC Department of Health, including: . Bureau of HIV . Bureau of Sexually Transmitted Infections . Bureau of Tuberculosis . Bureau of Communicable Diseases (Including Viral Hepatitis) . Public Health Laboratory . Bureau of Immunization . Bureau of Administration Over 1000 employees, 13 direct service clinical sites Oversee budget of nearly $300,000,000 Notable experience: o Coordinated response to local Legionella Clusters including coordination of epidemiology, environmental health, and lab responses including clusters related to cooling towers in Lenox Hill, Flushing, and Upper Washington Heights o Re-established funding for Tuberculosis Clinics and Field Services after drastic
    [Show full text]
  • Annual Report 2018-2019
    ANNUAL REPORT 2018-2019 1 2 CONTENTS A Letter from Our Executive Director 4 A Letter from the Chair of the Board 5 Our Namesakes 6 Celebrating Our History: 50 Years of LGBTQ Health 8 Timeline 12 Reflections on our History 14-17 Our Patients 18 A Year in Photos 22 Our Staff 24 Callen-Lorde Brooklyn 26 Board of Directors 28 Senior Leadership 29 Howard J. Brown Society 30 Our Supporters 32 ABOUT US Callen-Lorde is the global leader in LGBTQ healthcare. Since the days of Stonewall, we have been transforming lives in LGBTQ communities through excellent comprehensive care, provided free of judgment and regardless of ability to pay. In addition, we are continuously pioneering research, advocacy and education to drive positive change around the world, because we believe healthcare is a human right. 3 A LETTER FROM OUR EXECUTIVE DIRECTOR Dear Friends, Supporters, and Community Members, Fifty years ago, Sylvia Rivera and Marsha P. Johnson were among the first brick throwers in the Stonewall Rebellions, igniting the fire that began – slowly – to change LGBTQ lives. That same year, the beginnings of Callen- Lorde started when two physicians opened the St. Mark’s Health Clinic to provide free healthcare services to the ‘hippies, freaks, and queers’ in the East Village. Today, that little clinic is Callen-Lorde Community Health Center - a network of health centers soon to be in three boroughs of New York City and improving LGBTQ health worldwide. What has not changed in 50 years is our commitment to serving people regardless of ability to pay, our passion for health equity and justice for our diverse LGBTQ communities and people living with HIV, and our belief that access to healthcare is a human right and not a privilege.
    [Show full text]
  • ACT up by Geoffrey W
    ACT UP by Geoffrey W. Bateman Encyclopedia Copyright © 2015, glbtq, Inc. Entry Copyright © 2004, glbtq, inc. Reprinted from http://www.glbtq.com On March 24, 1987, the AIDS Coalition To Unleash Power, or ACT UP, staged its first action in New York City on Wall Street, protesting the Food and Drug Administration and the drug company Burroughs Wellcome. Converging on the site in the hundreds, protesters passed out flyers, disrupted traffic, and drew considerable media attention. One activist even built an effigy of the head of the FDA that he hung outside a church during the protest. Through this demonstration, ACT UP initiated its direct-action strategy in the fight against the AIDS epidemic. Using bold images and confrontational tactics, ACT UP worked to promote awareness of AIDS and challenge the complacency of politicians and government officials who had yet to respond adequately to the crisis. As its statement of purpose reads, "ACT UP is a diverse, non-partisan group united in anger and committed to direct action to end the AIDS crisis. We protest and demonstrate; we meet with government and public health officials; we research and distribute the latest medical information; we are not silent." Targeting Wall Street allowed ACT UP to highlight one of the most pressing needs of those living with AIDS in the late 1980s--effective and affordable drug treatment. Because of FDA policies, Burroughs Wellcome was the only company that made and sold AZT. The high cost of the drug--anywhere from $10,000 to $13,000 a year for one patient--and the belief that it was the only treatment option available prompted New York City activists to target this monopoly.
    [Show full text]